Tridergel Benzalkonium Chloride Wound Care Gel Recalled
Blaine Labs Inc is recalling Tridergel wound care gel nationwide due to current good manufacturing practice (CGMP) deviations. The product was manufactured in a facility under the same conditions as contaminated product.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall. The source text states CGMP deviations and manufacturing conditions related to contaminated product, but does not report any actual contamination, illnesses, or injuries. The hazard is regulatory non-compliance and potential cross-contamination risk without confirmed harm.
Plain-English summary
Blaine Labs Inc is recalling TRIFLUENT PHARMA TRIDERGEL Wound Care Gel (Benzalkonium Chloride 0.1%), 1.0 fl oz (29.6 mL) bottles nationwide in the United States. The recall affects approximately 519 units from Lot #BL3435 with an expiration date of 11/06/26.
The U.S. Food and Drug Administration identified current good manufacturing practice (CGMP) deviations related to the product being manufactured in the same facility under the same conditions as product found to be contaminated.
Consumers who have purchased this product should stop use immediately. For questions or to report any adverse effects, consumers should contact their healthcare provider or report the incident to the FDA.
The recalled product
- Product
- TRIDERGEL (BENZALKONIUM CHLORIDE)
- Brand
- TRIDERGEL
- Manufacturer
- Blaine Labs Inc
- Category
- Drug — Topical Wound Care
- Hazard
- cgmp-deviation
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: BL3435
- Exp. 11/06/26
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateDrogueria San Juan Isopropyl Alcohol 70% Recalled for Subpotency
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- ModerateGasco Isopropyl Alcohol 70% recalled nationwide for subpotency
FDA (Drugs) · 2026-07-15